Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02007967 · ClinicalTrials.gov registry record
Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation
A clinical trial, sponsored by University of Michigan.
- Terminated
- Registry status
- 12
- Enrollment target
NCT02007967: Clinical Trial study, sponsored by University of Michigan.
NCT02007967 is a clinical trial that was terminated before completion, run by University of Michigan. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02007967 was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The overall objective of this proposal is to examine the feasibility and accuracy of non-contrast magnetic resonance angiography (MRA) to comprehensively evaluate individuals referred for transcatheter aortic valve implantation (TAVI).
Primary Outcome
Compare luminal diameter for each segment of the ileofemoral arteries and aorta between MRI and CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2013-12 |
| Est. Completion | 2014-01 |
Why NCT02007967 stopped before completion
NCT02007967 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02007967 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02007967 about?
NCT02007967 is a clinical study titled "Non-Contrast Magnetic Resonance Angiography Assessment of Patients Referred for Transcatheter Aortic Valve Implantation". The overall objective of this proposal is to examine the feasibility and accuracy of non-contrast magnetic resonance angiography (MRA) to comprehensively evaluate individuals referred for transcatheter aortic valve implantation (TAVI).
What is the current status of trial NCT02007967?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2013-12. Estimated completion is 2014-01.
Who is sponsoring clinical trial NCT02007967?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia